Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

GEMO Study Collaborators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.'. Together they form a unique fingerprint.

Medicine & Life Sciences